Home > Healthcare > Medical Devices > Therapeutic Devices > Intensity Modulated Radiation Therapy Market
Intensity Modulated Radiation Therapy Market size was valued at USD 2.2 billion in 2022 and is estimated to register a CAGR of over 5.2% between 2023 and 2032. This therapy is an advanced technique in the field of radiation therapy designed to provide precise and targeted radiation doses to cancerous tumors while reducing the exposure to surrounding healthy tissues. Increasing prevalence of cancer is one of the prominent factors accelerating market growth.
According to the American Cancer Society, in 2022, an estimated 1.9 million new cases of cancer were diagnosed in the U.S. The commonly occurring cancers were breast cancer, prostate cancer, melanoma and others. Hence, surging cancer cases are expected to enhance the overall business progress.
Radiation therapy is an integrated part of modern comprehensive cancer management. Over the past decade, radiotherapy has come on leaps and bounds with several major technological breakthroughs that have increased precision and limited collateral damage. This means clinicians are able to boost doses, killing tumors more effectively, while further sparing surrounding healthy tissue. As technology continues to advance, the field of radiation therapy is likely to see further innovations which will enhance treatment outcomes and improve the quality of life for cancer patients.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Intensity Modulated Radiation Therapy Market Size in 2022: | USD 2.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.2% |
2032 Value Projection: | USD 3.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 145 |
Tables, Charts & Figures: | 217 |
Segments covered: | Radiation Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|